Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris

References

• Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Po AL, O’Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: Randomised controlled trial. Lancet 2004;364:2188–2195.
   PubMed Web of Science ®Google Scholar
• Purdy S. Acne vulgaris. Clin Evid 2006:2183–2201.
   PubMedGoogle Scholar
• Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003;121:20–27.
   PubMed Web of Science ®Google Scholar
• Webster GF. Inflammation in acne vulgaris. J Am Acad Dermatol 1995;33:247–253.
   PubMed Web of Science ®Google Scholar
• Rao S, Malik MA, Wilder L, Mott T. Clinical inquiries. What is the best treatment for mild to moderate acne? J Fam Pract 2006;55:994–996.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gover MD. Azelaic acid (15% gel) in the treatment of acne rosacea. Int J Dermatol 2007, 46, 533–538.
   PubMed Web of Science ®Google Scholar
• Iraji F, Sadeghinia A, Shahmoradi Z, Siadat AH, Jooya A. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. Indian J Dermatol Venereol Leprol 2007;73:94–96.
   PubMed Web of Science ®Google Scholar
• Shemer A, Weiss G, Amichai B, Kaplan B, Trau H. Azelaic acid (20%) cream in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol 2002;16:178–179.
   PubMed Web of Science ®Google Scholar
• Gollnick HPM, Graupe K. Azelaic acid for the treatment of acne. Comparative trials. J Dermatol Treatm 1989;1:27–30.
   Google Scholar
• Gollnick HPM, Graupe K, Detmar M, Zaumseil RP. Azelainsäure für die Behandlung der Akne: Pharmakologie, in vitro- und in vivo-Effekte, sowie klinische Ergebnisse und Toleranz. Z. Hautkr 1992;67:975–987.
   Google Scholar
• Gollnick HP, Graupe K, Zaumseil RP. [Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies]. J Dtsch Dermatol Ges 2004;2:841–847.
   PubMedGoogle Scholar
• Thiboutot D. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol 2008;7:13–16.
   PubMed Web of Science ®Google Scholar
• Holland KT, Bojar RA. Antimicrobial effects of Azelaic acid. J Dermatol Treatment 1993:4S8–4S11.
   Google Scholar
• Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991;41:780–798.
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ. Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction. J Drugs Dermatol 2008;7:s2.
   Google Scholar
• Worret WI, Fluhr JW. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]. J Dtsch Dermatol Ges 2006;4:293–300.
   PubMedGoogle Scholar
• Ochsendorf F. Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges 2006;4:828–841.
   PubMed Web of Science ®Google Scholar
• Elsaie ML, Choudhary S. Updates on the pathophysiology and management of acne rosacea. Postgrad Med 2009;121:178–186.
   PubMed Web of Science ®Google Scholar
• Korting HC, Schöllmann C. [Management of acne vulgaris: focus on clindamycin and zinc]. Hautarzt 2009;60:42–47.
   PubMed Web of Science ®Google Scholar
• Rizer RL, Sklar JL, Whiting D, Bucko A, Shavin J, Jarratt M. Clindamycin phosphate 1% gel in acne vulgaris. Adv Ther 2001;18:244–252.
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Hickman JG, Jarratt MT, Stewart DM, Levy SF. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg 2001;5:37–42.
   PubMed Web of Science ®Google Scholar
• Guay DR. Topical clindamycin in the management of acne vulgaris. Expert Opin Pharmacother 2007;8:2625–2664.
   PubMed Web of Science ®Google Scholar
• Tanghetti E. The impact and importance of resistance. Cutis 2007;80:5–9.
   PubMed Web of Science ®Google Scholar
• Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. Br J Dermatol 2005;153:395–403.
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Jitpraphai W, Bhambri S, Momin S. Clindamycin phosphate 1.2%-tretinoin 0.025% gel: Vehicle characteristics, stability, and tolerability. Cutis 2008;81:405–408.
   PubMed Web of Science ®Google Scholar
• McKeage K, Keating GM. Clindamycin/benzoyl peroxide gel (BenzaClin): A review of its use in the management of acne. Am J Clin Dermatol 2008;9:193–204.
   PubMed Web of Science ®Google Scholar
• Schlessinger J, Menter A, Gold M, Leonardi C, Eichenfield L, Plott RT, Leyden J, Wortzman M; ZIANA Study Group. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol 2007;6:607–615.
   PubMedGoogle Scholar
• Tschen E, Jones T. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin. J Drugs Dermatol 2002;1:153–157.
   PubMedGoogle Scholar
• Detmar M, Mayer-da-Silva A, Stadler R, Orfanos CE. Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. J Invest Dermatol 1989;93:70–74.
   PubMed Web of Science ®Google Scholar
• Mayer-da-Silva A, Gollnick H, Imcke E, Organos C. Azelaic acid vs. placebo: Effects on normal human keratinocytes and melanocytes. Electron microscopic evaluation after long-term application in vivo. Acta Derm Venereol (Stockh) 1987;67:116–122.
   PubMed Web of Science ®Google Scholar
• Blandon PT, Burke BM, Cunliffe WJ, Forster RA, Holland KT, King K. Topical azelaic acid and the treatment of acne: A clinical and laboratory comparison with oral tetracycline. Br J Dermatol 1986;114:493–499.
   PubMed Web of Science ®Google Scholar
• Stamatiadis D, Bulteau-Portois MC, Mowszowicz I. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol 1988;119:627–632.
   PubMed Web of Science ®Google Scholar
• Passi S, Picardo M, De Luca C, Nazzaro-Porro M. Mechanism of azelaic acid action in acne. G Ital Dermatol Venereol 1989;124:455–463.
   PubMedGoogle Scholar
• Zouboulis CC. [Acne vulgaris: The role of hormones.] Hautarzt 2010;61:107–114.
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Gilliland K, Light J, Lookingbill D. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 1999;135:1041–1045.
   PubMed Web of Science ®Google Scholar
• Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol 2000;43:S47–S50.
   PubMed Web of Science ®Google Scholar
• Shamban AT, Narurkar VA. Multimodal treatment of acne, acne scars and pigmentation. Dermatol Clin 2009;27:459–471.
   PubMed Web of Science ®Google Scholar
• Garg VK, Sinha S, Sarkar R. Glycolic acid peels versus salicylic-mandelic acid peels in active acne vulgaris and post-acne scarring and hyperpigmentation: A comparative study. Dermatol Surg 2009;35:59–65.
   PubMed Web of Science ®Google Scholar
• Breathnach AS. Melanin hyperpigmentation of skin: Melasma, topical treatment with azelaic acid, and other therapies. Cutis 1996;57(1 Suppl):36–45.
   PubMedGoogle Scholar
• Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther 1998;20:945–959.
   PubMed Web of Science ®Google Scholar
• Tanghetti E. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: A flexible component of acne management. Cutis 2009;84(5 Suppl):18–24.
   PubMed Web of Science ®Google Scholar
• Kircik L. Rapid and efficacious fixed-combination monotherapy: Desired results for the patient and improved adherence for the clinician. Cutis 2009;84(5 Suppl):5–11.
   PubMed Web of Science ®Google Scholar
• Eichenfield L. Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: Focus on acne patient benefits and clinical use. Introduction. Cutis 2009;84(5 Suppl):3–4.
   PubMed Web of Science ®Google Scholar
• Williams H. Clindamycin and benzoyl peroxide combined was more effective than either agent alone or placebo for acne vulgaris. Evid Based Med 2009;14:85.
   PubMedGoogle Scholar
• Thiboutot D, Zaenglein A, Weiss J, Webster G, Calvarese B, Chen D. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol 2008;59:792–800.
   PubMed Web of Science ®Google Scholar
• NilFroushzadeh MA, Siadat AH, Baradaran EH, Moradi S. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: A randomized control trial. Indian J Dermatol Venereol Leprol 2009;75:279–282.
   PubMed Web of Science ®Google Scholar
• Abdel-Naser MB, Zouboulis CC. Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris. Expert Opin Pharmacother 2008;9:2931–2937.
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Fischer TC, Wohlrab J, Barnard J, Alió AB. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris. Cutis 2009;84:223–9.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Wortzman M. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: Efficacy in acne vulgaris patients aged 12 to 18 years. Pediatr Dermatol 2009;26:257–261.
   PubMed Web of Science ®Google Scholar